04.01.2011 • NewsBASFMergers & Acquisitions (M&A)portfolio

BASF Acquires CRI/Criterion's Styrene Catalysts Business

BASF has announced that it has successfully completed its acquisition of CRI/Criterion's global styrene catalysts business.

As part of this agreement, BASF has acquired CRI/Criterion's customer list, contracts and exclusive and non-exclusive licenses for intellectual property, including applicable patents and know-how in the field of styrene catalysts, as well as CRI/Criterion's styrene catalysts inventory. There were no plant assets associated with the deal.

 

Company

Logo:

BASF SE

Carl-Bosch-Straße 38
67056 Ludwigshafen
Germany

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read